SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 79,124 shares at $27.32 ($2.2M) on 2023-06-05, disclosed to the SEC on 2023-06-06.
Open-market sale of $2.2M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.32 | 34,365 | $939K | 43.4% |
| 2 | $27.32 | 34,365 | $939K | 43.4% |
| 3 | $27.32 | 5,197 | $142K | 6.6% |
| 4 | $27.32 | 5,197 | $142K | 6.6% |
| Total | $27.32 avg | 79,124 | $2.2M | 100% |
| Filing → |
| VIR | SELL | 2025-10-24 | $3.6M | — | Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |